$35.00
0.802.34%
Last update: Nov 5, 4:55 PM
Castle Biosciences Inc
CSTLNASDAQ
The average analyst price target for Castle Biosciences is $42.70, 22.0% above the current price. Of 8 analysts, 8 rate it Buy. Targets range from $40 to $52. The latest change came on Nov 6, 2026, when Keybanc raised its price target on Castle Biosciences from $35 to $40 and kept an Overweight rating.
Price Target Range — 13 Quarters
Analyst Consensus — 8 Analysts
Rating Trend — Last 9 Months
